This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
Investigators found that simvastatin added to escitalopram for patients with obesity and major depressive disorder did not have increased antidepressive effects.
In the late 2010s, scientists at the Danish drugmaker Novo Nordisk developed a new weekly obesity treatment that targeted three hormones at once. In mice studies , the drug, which activated receptors of the GLP-1, GIP, and glucagon hormones, caused notable weight loss. But Novo shelved the therapy. The company was concerned about potential side effects of targeting glucagon, like increasing blood sugar and heart rate.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Compared with standard of care, camizestrant in combination with a CDK4/6 inhibitor shows promise in enhancing progression-free survival (PFS) for patients with advanced breast cancer.
People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness, a new observational study concludes, adding to a short list of concerns about eye health in people taking the powerful medications. The research, published Thursday in JAMA Ophthalmology , found that after one year, more than twice as many people on GLP-1 drugs developed neovascular age-related macular degeneration compared to similar people who were no
Approximately 11% of American adults have high cholesterol , and approximately 35% of these Americans are taking a statin. These drugs are designed to lower low-density lipoproteins (LDL), reduce triglyceride levels, and slightly raise high-density lipoproteins (HDL). Here’s what statin use looks like in 2025, including how many people are taking them, which statin medications are most commonly prescribed, and how many people experience side effects while taking these drugs.
Approximately 11% of American adults have high cholesterol , and approximately 35% of these Americans are taking a statin. These drugs are designed to lower low-density lipoproteins (LDL), reduce triglyceride levels, and slightly raise high-density lipoproteins (HDL). Here’s what statin use looks like in 2025, including how many people are taking them, which statin medications are most commonly prescribed, and how many people experience side effects while taking these drugs.
Artificial intelligence startup OpenEvidence inked a multi-year content agreement with the JAMA Network to use content from 13 medical journals to inform answers on its platform.
Global health threats don’t respect borders — they require strong collaborations and trust across partners. Yet a new policy from the National Institutes of Health blindsided U.S. researchers and could immediately upend the international research collaborations critical for understanding and responding to global health threats.
News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Mounjaro (tirzepatide) is a brand name glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Lilly. It’s approved by the Food and Drug Administration to treat Type 2 diabetes and may be prescribed off-label for weight loss. It’s injected under the skin once per week to help control blood sugar levels.
About 10% of patients report a penicillin allergy, but only around 1% are truly allergic. Recommending penicillin allergy testing can help patients determine whether they have a true allergy.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Mounjaro (tirzepatide) is an injectable prescription drug that is approved by the Food and Drug Administration to lower blood sugar in people with Type 2 diabetes. Categorized as a dual GIP/ GLP-1 receptor agonist , Mounjaro stimulates insulin production and suppresses appetite. Because of those effects, Mounjaro is sometimes prescribed off-label for weight loss.
Vadadustat and darbepoetin alfa show similar safety and efficacy in treating CKD-related anemia, with regional differences impacting cardiovascular risks.
Vasotec (enalapril maleate) is a name-brand prescription drug that’s FDA approved to treat hypertension (high blood pressure), heart failure, and asymptomatic left ventricular dysfunction. Like other angiotensin-converting enzyme (ACE) inhibitors, this medication is also used off-label to treat and prevent diabetic kidney disease. Without insurance, brand-name Vasotec costs about $1,025 for 30, 20 mg tablets.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer
Mounjaro (tirzepatide) is a brand-name prescription medication that’s approved by the Food and Drug Administration (FDA) to lower blood sugar levels in people with Type 2 diabetes. Manufactured by Lilly, Mounjaro is a once-weekly injection available in six different doses. It’s considered a glucose-dependent insulinotropic polypeptide (GIP) agonist/glucagon-like peptide-1 ( GLP-1 ) receptor agonist.
Implementation of the Plan-Do-Study-Act cycle in health system retail pharmacies significantly increased uptake of 20-valent pneumococcal conjugate vaccine among eligible adults.
Zepbound (tirzepatide) is a once-weekly injectable GIP/glucagon-like peptide-1 (GLP-1) receptor agonist that’s been approved by the Food and Drug Administration (FDA) to promote weight loss in adults with obesity or who are overweight with a weight-related health condition. It was later approved to treat sleep apnea in adults with obesity. While health insurance plans do not always provide coverage of Zepbound for weight loss, coverage may be more likely if the drug is prescribed for sleep apnea
Vijay Yadav warned people not to start downing taurine — an amino acid abundant in plants, animals and some energy drinks — just because his mice and monkey study suggested it might be an elixir for long life. But that doesn’t mean they listened. “The other day, I was talking to I think the scientific director of one of the largest pharma in the U.S., he was taking 14 grams of taurine per day,” said Yadav, or roughly 14 Red Bulls’ worth.
Wegovy (semaglutide) is a prescription glucagon-like peptide-1 (GLP-1) medication approved by the Food and Drug Administration (FDA) to reduce excess body weight and maintain weight reduction in people ages 12 and older with a diagnosis of obesity or in adults who are overweight with a weight-related health condition. It is also approved to reduce the risk of major adverse cardiovascular events in adults who have cardiovascular disease and are either overweight or have obesity.
On this week’s episode of “The Readout LOUD”: The Food and Drug Administration’s AI adventure, a deep look inside Novo Nordisk’s obesity stumble, and finally, another big M&A deal in biotech. The FDA has rolled out an internal AI tool called Elsa that, unlike its namesake Disney character, can’t seem to let go of mistakes.
A new analysis of the House-passed package based on Wednesday's Congressional Budget Office projections outlines billions in costs borne by hospitals due to Medicaid payment shortfalls and care for the uninsured.
In the first part of her Pharma Commerce video interview, Maggie McCullough, PolicyMaps CEO, explains how geospatial mapping can help identify and address emerging pharmacy deserts across the United States.
Alternative pharmacy benefit manager Serve You Rx is seeking to generate additional savings for its clients by adding two biosimilars for the popular drug Stelara to its formulary.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
247 
Let's personalize your content